https://www.selleckchem.com/pr....oducts/mps1-in-6-com
To test the ability of the hydrogels to protect cells while promoting function, diabetic NOD mice received intraperitoneal injections of PEGDA or MeHA microencapsulated canine islets. PEGDA microspheres reversed diabetes for the length of the study (up to 16 weeks). In contrast, islets encapsulated in MeHA microspheres at the same dose restored normoglycemia, but only transiently (3-4 weeks). Non-encapsulated canine islet transplanted at the same dose did not restore normoglycemia for any length of time. In conclusion, CSS
Like
Comment
Share
